SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001672351-16-000001
Filing Date
2016-04-25
Accepted
2016-04-25 12:42:53
Documents
1
Period of Report
2016-04-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1432
  Complete submission text file 0001672351-16-000001.txt   2880
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Issuer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELITE PHARMACEUTICALS, INC 165 NORTHVALE NJ 07647
Business Address
Pfeifer Eugene M (Reporting) CIK: 0001672351 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15697 | Film No.: 161588434